Familial Syndromic Esophageal Atresia Maps to 2p23-p24  by Celli, Jacopo et al.
Am. J. Hum. Genet. 66:436–444, 2000
436
Familial Syndromic Esophageal Atresia Maps to 2p23-p24
Jacopo Celli,1 Ellen van Beusekom,1 Raoul C. M. Hennekam,2 M. Esther Gallardo,8
Dominique F. C. M. Smeets,1 Santiago Rodrı´guez de Co´rdoba,8,9 Jeffrey W. Innis,5
Moshe Frydman,6,7 Rainer Ko¨nig,10 Helen Kingston,11 John Tolmie,12 Lutgarde C. P. Govaerts,3,4
Hans van Bokhoven,1 and Han G. Brunner1
1Department of Human Genetics, University Hospital Njimegen, Njimegen, The Netherlands; 2Clinical Genetics, University of Utrecht,
Utrecht; 3Department of Clinical Genetics, University of Maastricht, Veldhoven, The Netherlands; 4Department of Clinical Genetics,
University Hospital Rotterdam, Rotterdam; 5Departments of Pediatrics and Human Genetics, University of Michigan, Ann Arbor; 6Genetics
Institute and Department of Radiology, Sheba Medical Center, Tel-Hashomer, Israel; 7Sackler School of Medicine, Tel Aviv University, Tel
Aviv; 8Complement Genetics Laboratory Department of Immunology, Center of Biological Investigations, and 9Unit of Molecular Pathology,
Jimenez Diaz Foundation, Madrid; 10Institute of Human Genetics, Johan Wolfgang Goethe University, Frankfurt; 11Regional Genetic Service,
St Mary’s Hospital, Manchester, United Kingdom; and 12Duncan Guthrie Institute of Medical Genetics, Glasgow
Summary
Esophageal atresia (EA) is a common life-threatening
congenital anomaly that occurs in 1/3,000 newborns.
Little is known of the genetic factors that underlie EA.
Oculodigitoesophageoduodenal (ODED) syndrome
(also known as “Feingold syndrome”) is a rare auto-
somal dominant disorder with digital abnormalities, mi-
crocephaly, short palpebral fissures, mild learning dis-
ability, and esophageal/duodenal atresia. We studied
four pedigrees, including a three-generation Dutch fam-
ily with 11 affected members. Linkage analysis was in-
itially aimed at chromosomal regions harboring candi-
date genes for this disorder. Twelve different genomic
regions covering 15 candidate genes (∼15% of the ge-
nome) were excluded from involvement in the ODED
syndrome. A subsequent nondirective mapping ap-
proach revealed evidence for linkage between the syn-
drome and marker D2S390 (maximum LOD score 4.51
at recombination fraction 0). A submicroscopic deletion
in a fourth family with ODED provided independent
confirmation of this genetic localization and narrowed
the critical region to 7.3 cM in the 2p23-p24 region.
These results show that haploinsufficiency for a gene or
genes in 2p23-p24 is associated with syndromic EA.
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Introduction
Esophageal atresia (EA) is a common life-threatening
congenital condition. EA occurs in ∼1/3,000 newborns
(David and O’Callaghan 1975; Szendrey et al. 1985).
EA is frequently associated with other congenital anom-
alies. Of these, the most common are other gastrointes-
tinal atresias or stenoses, anomalies of the urinary tract,
and heart defects (Kimble et al. 1997). This combination
of features is often referred to as the “VATER associa-
tion” (MIM 192350). In some cases, EA is associated
with chromosomal abnormalities, such as deletions of
22q11 (Digilio et al. 1999), trisomy 18, and trisomy 21
(Beasley et al. 1997). A recent compilation of data on
chromosomal deletions failed to identify any region that
is specifically associated with EA (Brewer et al. 1998).
Nonsyndromic EA is considered to be a multifactorial
trait whose pathogenesis and causation are ill defined.
The recurrence of EA in some families (van Staey et al.
1984) suggests a contribution of genetic factors. In ad-
dition, several families with dominantly inherited forms
of syndromic EA have been reported. To identify a gene
involved in EA, we are studying families with the
autosomal dominant oculodigitoesophageoduodenal
(ODED) syndrome (MIM 164280). This syndrome has
been described under the following names: microceph-
aly-oculo-digito-esophageal-duodenal (MODED) syn-
drome, microcephaly mesobrachyphalangy and trache-
oesophageal fistula (MMT) syndrome, and Feingold
syndrome. The principal features of ODED syndrome
are clinodactyly of the 2d and 5th fingers; toe syndactyly,
typically of the 4th and 5th toes; microcephaly; short
palpebral fissures; and esophageal/duodenal atresia
(Feingold 1975; Ko¨nig et al. 1990; Brunner and Winter
1991; Courtens et al. 1997; Feingold et al. 1997; Fryd-
man et al. 1997; Innis et al. 1997). EA or duodenal
atresia is present in ∼33% of patients with ODED,
whereas minor digital abnormalities are present in all
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(Brunner and Winter 1991). We conducted a linkage
study of ODED syndrome in a large Dutch family with
11 affected members, as well as in three other small
families. We first excluded several chromosomal regions
containing candidate genes. We then started a genome-
wide scan on the remaining parts of the genome that
were not covered by our candidate genes. Our results
clearly indicate the presence of the ODED-syndrome
gene in the p23-p24 region of human chromosome 2.
Subjects
The four families with syndromic EA that were ana-
lyzed in this study all showed autosomal dominant in-
heritance of the ODED-syndrome phenotype, including
toe syndactyly, microcephaly, and esophageal and/or du-
odenal atresia (for pedigrees, see figs. 1 and 2). Family
A was described by Brunner and Winter (1991); family
B was described by Innis et al. (1997); and family C was
described by Frydman et al. (1997). Family D is an un-
reported family whose records were contributed by R.
Hennekam. Four additional isolated patients and small
families with ODED syndrome (Ko¨nig et al. 1990; Cour-
tens et al. 1997; H.K. and J.T., unpublished data) were
examined for mutations of the human SIX2 gene. In
these small families, as well as in the isolated patients,
the core features of ODED syndrome—namely, micro-
cephaly, limb abnormalities, and EA or duodenal atre-
sia—were present.
The family with nonsyndromic EA (fig. 3) lacked all
other ODED-syndrome characteristics (specifically, mi-
crocephaly, short palpebral fissures, and limb abnor-
malities) and was evaluated by L.C.P.G.
Material and Methods
Materials from Patients
After informed consent was obtained, venous blood
samples were collected from affected and unaffected
family members. The DNA used in this study was iso-
lated from peripheral blood lymphocytes of patients and
relatives, as described elsewhere (Miller et al. 1988).
Microsatellite PCR and Data Analysis
Polymorphic markers used were derived mainly from
the Ge´ne´thon genetic map (Dib et al. 1996). PCR re-
actions were performed in a 12-ml volume containing 50
ng of DNA; 30 ng of each primer; 200 mM dATP, dGTP,
and dTTP; 2.4 mM dCTP; 0.6 mCi a[32P]-dCTP; 10 mM
Tris-HCl pH 9.0; 50 mM KCl; 1.5 mM MgCl2; 0.1%
Triton-X100; and 0.3 U of Taq DNA polymerase
(GIBCO-BRL Life Technologies). After initial denatur-
ation at 94C for 5 min, 30 cycles of amplification at
94C for 1 min, at 55C for 2 min, and at 72C for 1
min, and a final extension at 72C for 6 min were per-
formed in a 96-well thermal cycler (M.J. Research). Am-
plified products were electrophoresed in 6.6% denatur-
ing polyacrylamide gels and were visualized by auto-
radiography on Kodak X-OMAT films.
Linkage calculations were performed, by use of the
LINKAGE package (version 5.03), on the basis of au-
tosomal dominant inheritance, with full penetrance for
the families with ODED syndrome and with incomplete
penetrance (50%) for the family with nonsyndromic EA.
The frequency of the mutant allele was set at .00001.
Penetrance was set at 100% for the families with ODED,
in accordance with other estimates (Brunner and Winter
1991). All patients with ODED have, at least, micro-
cephaly and limb abnormalities. As for the setting of
penetrance to 50% in the family with nonsyndromic EA,
this was deduced from the pedigree, and it is in agree-
ment with the penetrance of intestinal atresia in ODED
syndrome.
DNA Sequence Analysis
Exon 1 of the SIX2 gene was amplified from genomic
DNA, with the use of overlapping primers designed to
amplify the six domain from the N terminus of the gene
(Six2D  Six2B) and the homeobox domain (Six2A 
Six2B). The primer sequences were as follows: Six2A,
GCG TGC TCA AGG CCA AGG CCG TGG; Six2B,
CCT GTC GCG CTG CCG CCG GTT CT; and Six2D,
GCC ACC ATG TCC ATG TTG CC. PCR reactions
were performed in a 50-ml volume containing 100 ng of
DNA, 5 mM of each primer, 0.2 mM of each dNTP, 1.5
mM of MgCl2, 1 # PCR buffer (200 mM Tris-HCl pH
8.4, and 500 mM KCl) (GIBCO-BRL Life Technologies),
and 1 U of Taq DNA polymerase (GIBCO-BRL Life
Technologies). After initial denaturation at 94C for 2
min, 35 cycles of amplification at 94C for 30 s, at 70C
for 1 min, and at 72C for 1 min, and a final extension
at 72C of 6 min were performed in a PE 480 DNA
thermal cycler (PE Biosystems). Products were sequenced
with use of the Big Dye Terminator Cycle Sequencing
Ready Reaction Kit mix and were analyzed with a sem-
iautomated sequencer, Applied Biosystems model 377
(ABI/PE Biosystems).
Fluorescence In Situ Hybridization (FISH)
Four DNA probes were applied in our experiments;
all were derived from the WC2.2 YAC contig of the
Whitehead Institute for Biomedical Research/MIT Cen-
ter for Genome Research. To identify chromosome 2, a
chromosome paint for 2q was used. FISH procedures
were applied as described elsewhere (Suijkerbuijk et al.
1992). In brief, the probes were labeled with biotin-14-
dATP (GIBCO-BRL Life Technologies) while paint 2q
was labeled with digoxigenin-11-dUTP (Boehringer), by
Figure 1 Pedigrees used in the DNA-marker studies. Segregation of chromosome 2 markers is seen in the three-generation Dutch family
with ODED syndrome (family A). The blackened bar indicates the haplotype that segregates with the disease. Affected patients III:5 and III:7
show recombination at markers D2S352 and D2S131, respectively. Pedigrees of the two smaller families with ODED syndrome (families B and
C) confirm linkage to the 2p23-p24 region. A recombination at D2S390 in individual II:3 (family C) defines the proximal border of the linkage
interval.
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Figure 2 CA-repeat analysis of the microdeletion in 2p23-p24 in family D with ODED syndrome. In this family, the genotypes in the
affected mother and daughter are inconsistent with Mendelian inheritance for the markers between D2S2199 and D2S320. In the affected
daughter, these markers show only the father’s allele and not the allele that is present in the mother. The mother is also hemizygous for these
markers. Note that marker D2S2267 is either homozygous or hemizygous in individual II:1.
use of standard nick-translation. YACs were precipitated
with human Cot.1 DNA (Life Technologies), were dis-
solved in hybridization solution (2# SSC, 10% dextran
sulfate, 1% Tween-20, and 50% formamide, pH 7.0),
and were heat denatured. Slides were then incubated
with the probes for 35 h, followed by immunochemical
detection by means of avidin FITC and successive steps
with rabbit anti-FITC and mouse-antirabbit FITC-con-
jugated antibodies. Slides were evaluated in a Zeiss epi-
fluorescence microscope, and hybridization signals and
the chromosome counterstained with 4,6-diamidino-2-
phenylindole were analyzed with the Biological Detec-
tion Systems–image software package (ONCOR-Image).
Cloning and Mapping of Human SIX2
An 884-bp-long human SIX2 cDNA fragment con-
taining the ATG and TAG codons was obtained by re-
verse-transcriptase (RT)-PCR, with the use of primers
derived from the mouse Six2 gene sequence and of total
RNA prepared, by means of the guanidinium thiocya-
nate method (Chomczynski and Sacchi 1987), from 31-
wk-old human embryonic eyes. RT was performed with
the use of oligo-(dT) as a primer and with Moloney
murine leukemia virus RT. Confirmation that the se-
quence obtained was indeed human SIX2 was obtained
by the comparison of its predicted amino acid sequence
with the sequences of the human SIX1 and the mouse
Six1 and Six2 genes. Mapping of the human SIX2 gene
was performed with the Stanford Human Genome Cen-
ter G3 Radiation Hybrid Panel (Research Genetics), by
means of primers derived from the intronic sequences of
the SIX2 gene.
Results
To uncover the genetic basis of ODED, we started our
mapping efforts by focusing on chromosomal regions
containing candidate genes. Candidate genes were se-
lected on the basis of gene-expression patterns, the effect
of knockout mutations in mice, and the physiological
role of the corresponding proteins. We selected a total
of 15 candidate genes on the basis of their prominent
expression in developing esophagus and limb (e.g.,
PAX9; see Peters et al. 1997), on the basis of occurrence
of EA in a knockout animal (e.g., Hoxc4; see Boulet et
al. 1996), or because mutations in these genes caused
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Figure 3 FISH characterization of the microdeletion in 2p23-
p24 in family D with ODED syndrome. FISH with YAC probe 953G11
from 2p23-p24 shows only a single signal in a patient with ODED
syndrome (patient II:1 in family D).
Table 1
Combined Maximum LOD Scores for
Families A–C with ODED Syndrome
Intervala
(cM) Marker Zmax v
3.7 D2S168 1.614 .143
.0 D2S2200 2.047 .108
2.9 D2S131 3.393 .050
12.3 D2S149 3.608 .001
2.7 D2S144 3.007 .001
.7 D2S170 2.891 .064
6.4 D2S390 4.510 .001
D2S352 2.342 .106
a Between marker indicated and that
on line below.
other forms of intestinal atresias (e.g., ITGa6; see Pulk-
kinen et al. 1997). Genes encoding proteins involved in
retinoic-acid metabolism—such as CRABP, RAR, and
RXR—were considered candidates because of their role
in apoptotic processes in early development (Ba˚vik et al.
1997; Brickell et al. 1997; Dickman et al. 1997). We
also tested genomic regions in which deletions are as-
sociated with limb abnormalities that match those of
ODED syndrome (13q14-qter and 2q24-q31) (Brunner
and Winter 1991; Boles et al. 1995). In total, 12 different
regions of the genome were selected. These loci were
tested with markers at intervals of 5–10 cM in family
A shown in figure 1. No linkage was detected, which
allowed us to exclude ∼15% of the genome. We then
started a genomewide linkage analysis in family A, to
cover those areas not excluded by our candidate
gene–directed screening. Linkage was almost immedi-
ately detected with marker D2S170 (maximum LOD
score [Zmax] 3.91 at recombination fraction [v] 0) from
the 2p23-p24 region. Positive LOD scores were also
found with markers D2S390, D2S149, D2S352, and
D2S168 (table 1). Linkage was then confirmed for the
two smaller families (families B and C) (fig. 1). Families
A–C together give at for D2S390 (tableZ = 4.51 v = 0max
1). These cumulative two-point linkage results were con-
firmed by multipoint linkage analysis that showed the
presence of association with the disease, between mark-
ers D2S131 and D2S390, with Zmax = 5.1 at marker
D2S144. Haplotype analysis in family A (fig. 1) showed
a recombination event between the disorder and marker
D2S131 in affected individual III:7, which demarcates
the distal border of the linkage interval. Recombination
at marker D2S352 in an affected male (individual III:5)
established the proximal border of the region. Haplotype
analysis of the two other small families with ODED
syndrome showed a recombination event between mark-
ers D2S170 and D2S144 in an unaffected sibling (in-
dividual II:2) in family C. With the assumption of com-
plete penetrance, this crossover event restricts the linkage
area to 18 cM between D2S170 and D2S131. The hap-
lotype of family C also showed a recombination within
the minimal linkage region at marker D2S170 in II:3
(fig. 1). In family D, initial analysis showed that the
chromosome 2 marker alleles in the affected mother and
daughter are inconsistent with Mendelian inheritance for
marker D2S149 (fig. 2). Alternative primers were de-
signed for marker D2S149. Identical results were ob-
tained, indicating that this apparently null allele could
not be explained by a polymorphism in the primer se-
quences. Absence of a maternally inherited allele in in-
dividual II:1 was also detected for markers D2S2267,
D2S149, D2S2295, D2S2346, D2S2155, and D2S332.
The mother and the daughter each carried only a single
allele for these markers. These data are consistent with
the presence of a microdeletion of 2p23-p24, inherited
by an affected daughter from her affected mother (fig.
2). The microdeletion was confirmed by in situ hybrid-
ization, by use of YACs 953G11, 916C7, and 875B11
(fig. 3 and data not shown). Each of these YACs gave
only a single hybridization signal. We also tested these
YACs for the presence of markers used in the marker
study: D2S2346 was present in YAC 953G11; D2S312
gave signal in YAC 916C7 and in YAC 875B11. Other
markers used in this study that have been reported to
be present in these YACs (Whitehead Institute for Bio-
medical Research/MIT Center for Genome Research) are
markers D2S2155 and D2S332, which are present in
YAC 953G11, and marker D2S2346, which is present
in YAC 916C7.
For markers D2S2199 and D2S320, two alleles were
present in the affected child as well as in the mother.
Therefore, these markers are outside the deletion, on
either side (fig. 2). Marker D2S2267 showed only a sin-
gle allele in the affected daughter. Whether this repre-
sents homozygosity or hemizygosity cannot yet be de-
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Figure 4 Pedigree of family E with nonsyndromic familial EA. Marker D2S149 segregates with the nonsyndromic form of familial EA.
A recombination in individual IV-1 excludes markers proximal to D2S144.
termined. The combined data from the linkage analysis
in families A–C and the microdeletion in family D are
consistent with a localization of the ODED-syndrome
gene in 2p23-p24, between markers D2S2199 and
D2S320.
It is currently unknown whether ODED syndrome is
due to a mutation in a single gene or whether it might
represent a contiguous-gene syndrome. Our finding of a
small submicroscopic deletion in family D is consistent
with both hypotheses. We decided to explore the hy-
pothesis of a contiguous-gene syndrome by examining
a family with nonsyndromic EA, for linkage to 2p23-
p24. Interestingly, haplotype analysis in this small family
with nonsyndromic EA (fig. 4) is also consistent with an
assignment to 2p23-p24. However, the small size of this
family precludes more-definitive conclusions, and the
LOD score is only 0.35.
We identified the SIX2 gene as a possible candidate,
on the basis of homology mapping. The Six2 gene is a
member of the expanding family of homologues of the
Drosophila sine oculis gene (Oliver et al. 1995). The
Six2 gene was originally cloned in the mouse (Oliver et
al. 1995). Six2maps on mouse chromosome 17, between
Lhcgr (luteinizing hormone/choriogonadotropin recep-
tor) and Sos1, both of which map to 2p21-p22 in hu-
mans. This suggests that the human SIX2 gene might
also map to this region. The pattern of mRNA expres-
sion during embryogenesis of Six2 in the mouse is strik-
ingly similar to what might be expected for the ODED-
syndrome gene. Six2 has prominent expression in the
esophagus, pyloric region, hindbrain, and interdigital
mesenchyme (Oliver et al. 1995). We used primers to
amplify 546 bp of the human SIX2 cDNA sequence
containing the Six and homeobox domains (fig. 5). The
analysis failed to identify any abnormalities in a panel
of eight unrelated patients with ODED syndrome. Map-
ping of the human SIX2 gene was performed with the
Stanford Human Genome Center G3 Radiation Hybrid
Panel (Research Genetics), by use of primers derived
from the intronic sequences of the SIX2 gene. The sta-
tistical evaluation of the results confirmed the predicted
location for SIX2 and placed it on chromosome 2,
20 cM from sequence-tagged-site marker SHGC-11647
(LOD score 5.76), within the 5.2-cM interval defined by
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Figure 5 Human SIX2 partial cDNA sequence. Primers used are
in italic lowercase type; start and stop codons are in boldface type;
the SIX domain is underlined; and the homeobox domain is underlined
twice.
Ge´ne´thon markers D2S119 and D2S288. This is outside
the ODED-syndrome critical region. These mapping re-
sults, as well as our failure to identify mutations in the
two major domains of the SIX2 gene, exclude it as the
ODED-syndrome gene.
Discussion
We report the assignment of a gene for the autosomal
dominant syndrome of EA, syndactyly, and microceph-
aly (ODED or Feingold syndrome) to the short arm of
chromosome 2. Significant evidence for linkage was ob-
tained in a large Dutch kindred. Analysis of two smaller
kindreds confirmed the original assignment and nar-
rowed the interval to a 18.3-cM region between markers
D2S131 and D2S170.
In a smaller family, an apparently null allele for mark-
ers D2S2267, D2S149, D2S2295, D2S2346, D2S2155,
and D2S332 was inherited by an affected daughter from
her affected mother. These findings are best explained
by a microdeletion in 2p23-p24. This interpretation was
supported by FISH analysis, which indicated the pres-
ence of a single copy of probes from 2p23-2p24. The
combined data from the linkage analysis and from the
microdeletion suggest that the critical region for the
ODED-syndrome gene lies in a 7.3-cM region between
markers D2S2199 and D2S320 (fig. 6).
The SIX2 gene appeared to be a strong candidate, on
the basis of its expression pattern during mouse devel-
opment (Oliver et al. 1995) and its localization in a
mouse chromosome 17 region that is syntenic to human
2p21-p22. However, the lack of mutations in SIX and
homeobox domains of SIX2 in eight unrelated families
with ODED syndrome and the subsequent localization
of SIX2 outside the ODED-syndrome critical interval,
by means of radiation-hybrid mapping, excluded SIX2
as the ODED-syndrome gene.
The ODED linkage region contains the locus for syn-
decan-1 precursor (SYND1), which is a possible posi-
tional candidate gene. The syndecans are a family of
cell-surface heparan sulfate proteoglycans that interact
with adhesion molecules, growth factors, and a variety
of other molecules. SYND1 is thought to function as
a receptor for extracellular-matrix components and
growth factors that are differentially expressed during
development (David et al. 1993). Synd1 is strongly ex-
pressed in esophageal, facial, and digital mesenchyme in
mouse embryos (Mitsiadis et al. 1995). Fine mapping of
the SYND1 gene will be required in order to establish
whether the gene is contained within the deletion area
in family D.
Study of knockout mice may help to unravel the path-
ways that are involved in normal esophageal develop-
ment. Several such targeted mutations have been re-
ported to be associated with EA, but none of these genes
map to the ODED-syndrome critical region. EA is pre-
sent in mice mutants carrying nonfunctional alleles of
Hoxc4 (Boulet and Capecchi 1996) and in mice that
have a homozygous null mutation for theGli2 gene (Mo-
toyama et al. 1998). The human GLI2 gene is located
in 2q14, which is well outside the ODED-syndrome re-
gion identified here. Similarly, the occurrence of EA in
mice that have a homozygous null mutation of the sonic
hedgehog (Shh) gene (Litingtung et al. 1998) does not
provide a likely explanation for EA in humans. The SHH
gene is located on chromosome 7q36 in humans, and
mutations are specifically associated with holoprosen-
cephaly (Roessler et al. 1996).
Like many other structural malformations in humans,
isolated EA is probably a multifactorial disorder. A num-
ber of familial cases have been identified (Casteels et al.
1993), but the actual recurrence risk is only ∼1% in
sporadic cases (van Staey et al. 1984). Because ODED
syndrome carries a 30% risk of EA and/or duodenal
atresia and because ODED syndrome is probably still
underdiagnosed, it is possible that most cases of familial
EA are in fact due to this syndrome. We have already
identified four families with ODED syndrome from the
Netherlands alone, indicating that the syndrome may
not be extremely rare. Also, the microcephaly associated
with the syndrome is mild and is associated with minimal
learning disability or even normal intelligence (Brunner
and Winter 1991; Feingold et al. 1997; Kawame et al.
1997). Some cases lack the distinctive toe syndactyly
(Feingold et al. 1997) and may easily be misdiagnosed
as nonsyndromic EA. Our finding of a microdeletion in
2p23-p24 in family D raises the possibility that ODED
syndrome could represent a contiguous-gene syndrome.
In this regard, it is of interest that the results of haplotype
analysis conducted on a small family with nonsyndromic
familial EA are consistent with a causative gene in 2p23-
p24 (fig. 4). Families with autosomal dominant micro-
cephaly (Rossi et al. 1987) and families with autosomal
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Figure 6 Comparison of linkage intervals for families A–C with ODED syndrome, the microdeletion in family D (the diagonally barred
area indicates possible reduction of the deleted area; see text), and the cosegregating haplotype in nonsyndromic family E. In family E, the
linkage interval continues more distally. Distances (in cM) between each marker and the next are indicated and are computed on the basis of
average distances on the Ge´ne´thon map for chromosome 2 (Dib et al. 1996).
dominant EA (Pletcher et al. 1991) but without other
ODED-syndrome characteristics have been reported. If
such families are also consistent with linkage to 2p23-
p24, this would strengthen the hypothesis that ODED
syndrome is in fact a microdeletion syndrome.
The best name for the syndrome studied here re-
mains to be found. In view of the expanding pheno-
type, which now includes deafness and kidney anom-
alies in some cases, we suggest that the term “Feingold
syndrome” be used, in preference to the acronyms
“ODED,” “MODED,” or “MMT.”
In conclusion, haploinsufficiency of a gene or genes
in 2p23-p24 causes syndromic EA (Feingold or ODED
syndrome). Cloning of the ODED-syndrome gene should
shed light on a significant proportion of inherited EA.
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